Lyell Immunopharma, Inc.

Qube Research & Technologies Ltd LYEL

Report date

12/31/2023

Quarter

2023 Q4

Filed

2/13/2024

Shares

8,500

Value ($000)

16

Weight

0.0%

2021 Q2 - 2023 Q4 (3 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q4	2/13/2024	16	0.0%	8,500	12/31/2023
2021 Q4	2/10/2022	87	0.0%	11,268	12/31/2021
2021 Q2	8/13/2021	739	0.0%	45,505	6/30/2021